Enhanced Cancer Subtyping via Pan-Transcriptomics Data Fusion, Monte-Carlo Consensus Clustering, and Auto Classifier Creation
Linton-Reid, K.; Thompson, J.; Clifford, H.
Show abstract
Subtyping of tumor transcriptome expression profiles is a routine method used to distinguish tumor heterogeneity. Unsupervised clustering techniques are often combined with survival analysis to decipher the relationship between genes and the survival times of patients. However, the reproducibility of these subtyping based studies is poor. There are multiple reports which have conflicting subtype and gene-survival time relationship results. In this study, we introduce the issues underlying the lack of reproducibility in transcriptomic subtyping studies. This problem arises from the routine analysis of small cohorts (< 100 individuals) and use of biased traditional consensus clustering techniques. Our approach carefully combines multiple RNA-sequencing and microarray datasets, followed by subtyping via Monte-Carlo Consensus Clustering and creation of deep subtyping classifiers. This paper demonstrates an improved subtyping methodology by investigating pancreatic ductal adenocarcinoma. Importantly, our methodology identifies six biologically novel pancreatic ductal adenocarcinoma subtypes. Our approach also enables a degree of reproducibility, via our pancreatic ductal adenocarcinoma classifier PDACNet, which classical subtyping studies have failed to establish.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Novel ratio-metric features enable the identification of new driver genes across cancer types 96%
- Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning 95%
- Discovering Key Transcriptomic Regulators in Pancreatic Ductal Adenocarcinoma using Dirichlet Process Gaussian Mixture Model 94%
Similar papers in this journal
- An algorithm for drug discovery based on deep learning with an example of developing a drug for the treatment of lung cancer 92%
- Predicting GD2 expression across cancer types by the integration of pathway topology and transcriptome data 92%
- BC-Predict: Mining of signal biomarkers and multilevel validation of cascade classifier for early-stage breast cancer subtyping and prognosis 92%
Similar papers in this journal
- Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches 96%
- Unsupervised Discovery of Risk Profiles on Negative and Positive COVID-19 Hospitalized Patients 94%
- Enrichment analysis on regulatory subspaces: a novel direction for the superior description of cellular responses to SARS-CoV-2 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.